| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/27/2008 | WO2008034648A1 Process for the production of a fine chemical |
| 03/27/2008 | WO2008034622A2 A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator |
| 03/27/2008 | WO2008034573A1 Compositions and devices for electro-filtration of molecules |
| 03/27/2008 | WO2008034388A1 Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof |
| 03/27/2008 | WO2008034338A1 S-adenosylmethionine synthetase mutants, the dnas encoding the same and uses of the mutants |
| 03/27/2008 | WO2008034249A1 High-throughput automated cellular injection system and method |
| 03/27/2008 | WO2008034186A1 Dna markers for meat tenderness |
| 03/27/2008 | WO2008034161A1 Neuroprotective peptide inhibitors of ap-1 signaling and uses therefor |
| 03/27/2008 | WO2008015447A3 Enhanced expression method |
| 03/27/2008 | WO2008009437A3 Sdf-i binding nucleic acids |
| 03/27/2008 | WO2008005619A8 Shade tolerance in plants |
| 03/27/2008 | WO2008003666A8 Transplastomic plants expressing lumen-targeted protein |
| 03/27/2008 | WO2008003473A3 Compositions and methods for enhancing the efficacy of il-2 mediated immune responses |
| 03/27/2008 | WO2008003066A3 Apparatus, compositions, and methods for assessment of chronic obstructive pulmonary disease progression among rapid and slow decline conditions |
| 03/27/2008 | WO2008001126A3 Compositions and methods relating to cellular targeting |
| 03/27/2008 | WO2007143630A3 Treatment of neurofibromatosis with hsp90 inhibitors |
| 03/27/2008 | WO2007141274A3 Human binding molecules having killing activity against staphylococci and uses thereof |
| 03/27/2008 | WO2007140599A8 Assessment of risk for colorectal cancer |
| 03/27/2008 | WO2007138444A3 Genetic markers for high oleic acid content in plants |
| 03/27/2008 | WO2007135194A3 Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity |
| 03/27/2008 | WO2007134876A3 HIGH AFFINITY HUMAN AND HUMANIZED ANTI-α5β1 INTEGRIN FUNCTION BLOCKING ANTIBODIES WITH REDUCED IMMUNOGENICITY |
| 03/27/2008 | WO2007134294A3 Novel chlorella species and uses therefor |
| 03/27/2008 | WO2007127219A3 Targeted delivery to leukocytes using protein carriers |
| 03/27/2008 | WO2007118790A3 Active potassium channel transporters (akt) and their use to create stress tolerant plants |
| 03/27/2008 | WO2007115837B1 Combination of an anti-edb fibronectin domain antibody/ il2 fusion protein and a further small molecule |
| 03/27/2008 | WO2007113331A3 Method to inhibit the propagation of an undesired cell population |
| 03/27/2008 | WO2007107775A3 Preparation of oligonucleotides with photoswitchable properties |
| 03/27/2008 | WO2007105002A3 Nucleic acid molecules involved or associated with abscission |
| 03/27/2008 | WO2007100577A3 Development of a chlamydia sp. vaccine strain |
| 03/27/2008 | WO2007095316A3 Compositions and methods for oligonucleotide formulations |
| 03/27/2008 | WO2007095069A3 Nf-ya activates multiple hematopoietic stem cell (hsc) regulatory genes and promotes hsc self-renewal |
| 03/27/2008 | WO2007081204A3 Nucleic acid molecules and collections thereof, their application and modification |
| 03/27/2008 | WO2007080127A3 Dsrna as insect control agent |
| 03/27/2008 | WO2007080126A3 Dsrna as insect control agent |
| 03/27/2008 | WO2006105251A3 Electrosonic cell manipulation device and method of use thereof |
| 03/27/2008 | WO2006056480A3 Means and methods for detecting methylated dna |
| 03/27/2008 | WO2005105984A3 Culture conditions and growth factors affecting fate determination, self-renewal and expansion of mouse spermatogonial stem cells |
| 03/27/2008 | WO2005048733A3 Methods of producing specialty grain to segment markets |
| 03/27/2008 | WO2001022921A3 Prevention of atherosclerosis and undesired blood clotting by reducing von willebrand factor |
| 03/27/2008 | US20080078005 Transgenic plants expressing a cellulase |
| 03/27/2008 | US20080078004 Expression vector comprising nucleotide sequences coding serine/threonine kinase for use in generation stress tolerant maize |
| 03/27/2008 | US20080078001 Method for making homozygous genetic modifications |
| 03/27/2008 | US20080078000 Conditioned culture media |
| 03/27/2008 | US20080077999 Using Nonhuman Animal Model, Method of Measuring Transcription Activity Method of Measuring Cell Quantity and Method of Measuring Tumor Volume |
| 03/27/2008 | US20080077372 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 03/27/2008 | US20080076908 Short interfering RNA sequences for use as therapeutic tools in treatment of cancer, diabetes and nervous system disorders |
| 03/27/2008 | US20080076904 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 03/27/2008 | US20080076732 Gene expression control DNA element and associated protein |
| 03/27/2008 | US20080076731 Control of NK cell function and survival by modulation of ship activity |
| 03/27/2008 | US20080076729 antiinflammatory; cystic fibrosis; |
| 03/27/2008 | US20080076728 Novel method of protecting islet cells from apoptosis during the donor harvesting process |
| 03/27/2008 | US20080076713 Peptides selectively lethal to malignant and transformed mammalian cells |
| 03/27/2008 | US20080076712 Before cardiopulmonary bypass surgery or coronary artery bypass grafting; injecting a polypeptide preferential inhibitor of kallikrein, rather than aprotinin |
| 03/27/2008 | US20080076709 Isolated polypeptide, encoded by nucleic acid sequence, a vector from Staphylococcus; use for activators or inhibitors in therapy, antigen for vaccination, antibodies; antibacterial agent treating Staphylococcus infections; biodrugs |
| 03/27/2008 | US20080076701 double stranded ribonucleic acid is conjugated to the peptide; interfering ribonucleic acid with a delivery peptide; biodrug treating influenza in animal, inflammation occurs in arthritis, psoriasis |
| 03/27/2008 | US20080076673 Engineered binding proteins |
| 03/27/2008 | US20080076672 Methods for Identifying Genes Essential to the Growth of an Organism |
| 03/27/2008 | US20080076671 Applications of Nucleic Acid Fragments |
| 03/27/2008 | US20080076180 Method for producing organisms immune to all known viruses and unable to interbreed with other populations by re-encoding their genomes to make use of an alternate genetic code |
| 03/27/2008 | US20080076179 Sugar and lipid metabolism regulators in plants |
| 03/27/2008 | US20080076178 Methods for the production of plants resistant to HPPD herbicides |
| 03/27/2008 | US20080076177 Plasmid comprising nucleotide sequences coding vaccine specific to newcastle disease virus hemagglutinin-neuraminidase (HN) for use in prevention and treatment of viral diseases in plants |
| 03/27/2008 | US20080076175 Generating transgenic lymphoid cell comprising sequences coding immunoglobulin epitope for use in tissue targeted therapies |
| 03/27/2008 | US20080076174 Using site specific mutation as tool in directed protein evolution |
| 03/27/2008 | US20080076173 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 03/27/2008 | US20080076172 Vectors for tissue-specific replication |
| 03/27/2008 | US20080076167 Culturing cell comprising exogenous nucleic acid molecule encoding polypeptide capable of producing 3-hydroxypropionic acid from phosphoenolpyruvate (PEP), pyruvate, or lactate |
| 03/27/2008 | US20080076166 Method For Producing Polyunsaturated Fatty Acids In Transgenic Organisms |
| 03/27/2008 | US20080076164 Producing oils and/or lipids having high content of polyunsaturated fatty acids containing at least two double bonds in recombinant animals comprising ketoacyl-CoA reductase genes |
| 03/27/2008 | US20080076163 L-cysteine-producing microorganism and a method for producing L-cysteine |
| 03/27/2008 | US20080076161 Using expression vector comprising nucleotide sequences coding malaria antigen (LSA-NRC) and/or protein synthesis complex (MCP) to transform bacterial host and propagate preferential polypeptides |
| 03/27/2008 | US20080076160 Recombinase polymerase amplification |
| 03/27/2008 | US20080076157 Expression vector comprising nucleotide sequences coding signal sequences for transport of heterologous protein to cytoplasm of microorganism; improving exogenous gene expression |
| 03/27/2008 | US20080076156 Process for production of recombinant proteins as a soluble form |
| 03/27/2008 | US20080076154 Maltose-1-phosphate-producing enzyme |
| 03/27/2008 | US20080076153 Expression vector comprising nucleotide sequences coding microorganismal polypeptide for use in generating agents for prevention and treatment of infection |
| 03/27/2008 | US20080076152 Heat and alkali resistant hydrolase for use in saccharification of lignocellulosic feedstocks, production of fermentable sugars and fuel alcohol, improving digestibility of feeds, pulp and paper processing and releasing dye from and softening denim |
| 03/27/2008 | US20080076151 Compositions for controlling hair growth |
| 03/27/2008 | US20080076148 Using presence hyaluronic acid on surface of cell as evaluative tool in screening for preferential progenitor cells |
| 03/27/2008 | US20080076141 Nucleotide sequences coding transferase for use in identifying modulators for prevention and treatment of cell proliferative diseases |
| 03/27/2008 | US20080076136 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement |
| 03/27/2008 | US20080076126 Using blot analysis to monitor induction of monooxygenases in plants; enhancing biosynthesis of phenylpropanoids, alkaloids, terpenoids, lipids, cyanogenic glycosides, and glucosinolates |
| 03/27/2008 | US20080075763 Polycationic sterol derivatives as transfection agents |
| 03/27/2008 | US20080075744 Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine |
| 03/27/2008 | US20080075741 Recombinant P. falciparum merozoite protein-1 42 vaccine |
| 03/27/2008 | US20080075740 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 03/27/2008 | US20080075739 Attenuated Salmonella SP12 Mutants as Antigen Carriers |
| 03/27/2008 | US20080075737 inducing an immune response to an HIV antigen; genetic engineered polypeptide; inserted into cell; improves or restores the blood clotting time, blood disorders; gene therapy |
| 03/27/2008 | US20080075735 Demethylated and/or oxidized membrane DNA |
| 03/27/2008 | US20080075733 receptor for advanced glycosylation end products polypeptide directly linked to a polypeptide comprising a CH2 domain of an immunoglobulin; biodrug for treating amyloidosis, Alzheimer's disease, cancer, autoimmune disease, inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis |
| 03/27/2008 | US20080075727 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/27/2008 | US20080075726 Anti-IL-6 monoclonal antibodies and uses thereof |
| 03/27/2008 | US20080075724 Nucleotide sequeces coding protein for use in the detection, diagnosis and treatment cell proliferative, autoimmune diseases, inflammation and infection; biodrugs as antiinflammatory agents, antiproliferative agents |
| 03/27/2008 | US20080075720 fusion proteins comprising antibody variable domains that binds to factor B and a targeting moiety comprising a complement receptor or fragment, used to reduce or prevent airway hyperresponsiveness and inflammation, for treating ischemia-reperfusion injuries, rhinitis and respiratory system disorders |
| 03/27/2008 | US20080075717 Antigen Imitating Extracellular Areas of Membrane Proteins of Type III Produced from Intracellular Pathogenic Micro-Organisms, Derived Conformational Antibodies and the Use Thereof |
| 03/27/2008 | US20080075713 isomerase enzymes and ATP-binding cassette (ABC) transport proteins, used for controlling metabolism of triglycerides; diagnosis, prevention and treatment of metabolic disorders |
| 03/27/2008 | US20080075704 Time varying electromagnetic force ("TVEMF") expanded blood stem cells from a mammal, used for repair of tissues |
| 03/27/2008 | US20080075703 using a mixture of cells including connective tissue cells transfected or transduced with genes encoding transforming growth factors or bone morphogenic proteins, used for regenerating cartilage and treatment of osteoarthritis; somatic cell gene therapy; tissue-targeted therapy |
| 03/27/2008 | US20080075702 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 03/27/2008 | US20080075701 a mixture of magnetic nanoparticles and nucleic acids, transfected gene, deoxyribonucleic acids and/or ribonuecleic acids, encapsulated in hydrophilic liposomes; transfection efficiency to cells |